Showing results (151-160 of 946) with videos related to
Sort By:
Pageof 95
Synapse (New York, N.Y.)|July 1, 1997
Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmosetG M Mackenzie, M J Jackson, P Jenner, et al.Neuroscience|January 1, 1984
A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slicesR W Kerwin, N M Rupniak, P Jenner, et al.European Journal of Pharmacology|October 1, 1976
The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleusI Donaldson, A Dolphin, P Jenner, et al.Neuroscience Letters|August 23, 1996
D3 receptor expression within the basal ganglia is not affected by Parkinson's diseaseM J Hurley, C M Stubbs, P Jenner, et al.Psychopharmacology|February 1, 1995
Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primateK K Gnanalingham, A J Hunter, P Jenner, et al.Neuroscience Letters|October 1, 1993
Parallel alterations in Met-enkephalin and substance P levels in medial globus pallidus in Parkinson's disease patientsM L de Ceballos, A Fernandez, P Jenner, et al.Journal of Neurochemistry|January 1, 1993
Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's diseaseK W Lange, F R Wells, P Jenner, et al.Brain Research|June 2, 1987
Localization of neurotensin receptors in the forebrain of the common marmoset and the effects of treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineC M Waters, S P Hunt, P Jenner, et al.Brain Research|October 2, 1992
Transplantation of embryonic mesencephalic and medullary raphe neurons to the neostriatum of rats with unilateral 6-hydroxydopamine lesionsY Takeuchi, T Sawada, S Blunt, et al.Peptides|January 1, 1995
Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's diseaseA Fernandez, P Jenner, C D Marsden, et al.Pageof 95